Why Triple Agonism May Offer Unique Benefits Retatrutide distinguishes itself from other GLP-1 medications through its triple-agonist mechanism, simultaneously activating GLP-1, GIP, and glucagon receptors
it remains effective for blood sugar management but is often considered less potent for weight reduction than newer medications
This shift is why some people experience post-cholecystectomy syndrome, which can include symptoms like loose stools, gas, or bloating after eating certain foods
Below is your clear, nurse-approved breakdown
Book Now for a Free Consultation
Persistent symptoms lasting beyond initial treatment adaptation warrant urological evaluation, including urinalysis, post-void residual measurement, and potentially cystoscopy or imaging studies depending on clinical presentation